Bunkerhill MAC vs ClearRead CT

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 75/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Bunkerhill MAC

by Bunkerhill Health

ClearRead CT

by RIVERAIN TECHNOLOGIES

AI Verdict

Bunkerhill MAC is highly specialized in detecting and quantifying Mitral Annular Calcification (MAC) on CT scans, integrating with a generative AI platform for clinical reasoning and care coordination. ClearRead CT offers a broader cardiothoracic AI suite, including Coronary Artery Calcification (CAC) scoring and advanced pulmonary nodule detection with vessel suppression. While both leverage AI on CT scans for cardiovascular risk identification, Bunkerhill MAC focuses exclusively on MAC, whereas ClearRead CT provides a more comprehensive solution for both cardiac and pulmonary findings.

Choose Bunkerhill MAC if…

Choose Bunkerhill MAC if your primary objective is the precise, AI-driven identification and quantification of mitral annular calcification (MAC) from routine, non-gated chest CT scans. This tool is ideal for organizations focused on early cardiovascular risk identification specifically related to MAC and leveraging a generative AI platform for automated follow-up and care coordination.

View Bunkerhill MAC →

Choose ClearRead CT if…

Choose ClearRead CT if your radiology department requires a comprehensive AI suite for broader cardiothoracic health, encompassing both advanced pulmonary nodule detection and coronary artery calcification (CAC) analysis on ungated CTs. This tool is best suited for improving diagnostic accuracy, reducing reading times, and streamlining workflows across a wider range of chest CT findings, including nodule characterization and tracking with patented vessel suppression.

View ClearRead CT →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Bunkerhill MAC	ClearRead CT
Pricing	Unknown	Contact for pricing
Deployment	Cloud-based, integrates with EHRs.	On-premise (stand-alone server, virtual machine) and Cloud
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Bunkerhill MAC

Bunkerhill MAC integrates with the Carebricks generative AI platform, which is designed to automate next steps in clinical workflows, such as notifying care teams or generating documentation. This suggests a highly integrated and comprehensive user experience that extends beyond just image analysis.

Clinical Value

ClearRead CT

ClearRead CT offers a broader range of clinical applications, including pulmonary nodule detection and coronary artery calcification analysis, with quantifiable improvements. It is proven to reduce total reading time by up to 36% and improve detection accuracy by 29% in missed actionable nodules, demonstrating significant clinical impact.

Pricing & Value

Tie

Both tools explicitly state 'contact for pricing' in their descriptions. Without specific pricing information or detailed return on investment (ROI) studies for either product, it is impossible to conduct a head-to-head comparison on this dimension.

Enterprise Readiness

ClearRead CT

ClearRead CT offers flexible deployment options (on-premise and cloud) and explicitly states it 'operates with VA and other healthcare institutions,' indicating proven scalability and robust enterprise-grade capabilities. Its ISO27001 certification further highlights its commitment to information security.

Innovation

Bunkerhill MAC

Bunkerhill MAC leverages 'Generative AI for clinical reasoning and action' through its Carebricks platform, aiming to analyze patient data, surface insights, and automate next steps. This represents a more advanced and forward-looking approach to AI beyond mere detection, focusing on comprehensive clinical intelligence.

Support & Docs

ClearRead CT

Riverain Technologies provides a dedicated 'Support' page with clear contact information, options to submit support tickets, and a comprehensive resource library including FAQs, system requirements, workflows, and explicit mentions of user and administrator manuals. Bunkerhill Health's information on this dimension is not as readily available through public searches.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Bunkerhill MAC	ClearRead CT
Name	Bunkerhill MAC	ClearRead CT
Company	Bunkerhill Health	RIVERAIN TECHNOLOGIES
Primary Focus	Detection and quantification of Mitral Annular Calcification (MAC)	Pulmonary nodule detection and coronary artery calcification analysis
Key Features (Cardiology)	AI-powered detection and quantification of Mitral Annular Calcification (MAC), Identifies patients at increased cardiovascular risk	Coronary Artery Calcification (CAC) Scoring (ungated, non-contrast CTs)
Key Features (Other)	Integrates with the Carebricks generative AI platform for clinical reasoning and action, Supports automated workflows for follow-up and care coordination	Pulmonary Nodule Detection (solid, part-solid, ground glass), Patented Vessel Suppression (Clear Visual Intelligence), Nodule Characterization and Measurement, Automated Nodule Tracking and Comparison to Prior Exams, Reduced Reading Time (up to 36%), Improved Detection Accuracy (29% reduction in missed actionable nodules)
Specialties	Cardiology, Radiology	Cardiology, Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill MAC and ClearRead CT.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical conditions each AI tool is designed to detect?

Bunkerhill MAC is specifically designed to detect and quantify mitral annular calcification (MAC) on routine CT scans, aiding in early cardiovascular risk identification. ClearRead CT, on the other hand, focuses on enhancing pulmonary nodule detection and performing coronary artery calcification (CAC) analysis in CT scans.

What types of calcifications do these tools analyze?

Bunkerhill MAC is focused solely on the detection and quantification of Mitral Annular Calcification (MAC). ClearRead CT includes Coronary Artery Calcification (CAC) scoring as part of its suite of features.

How do these tools integrate into existing clinical workflows and IT infrastructure?

Bunkerhill MAC is cloud-based and integrates with existing EHRs and clinical systems via the Carebricks platform, supporting automated workflows for follow-up and care coordination. ClearRead CT offers both on-premise (stand-alone server, virtual machine) and cloud deployment options, with seamless PACS integration and vendor-neutral processing.

Beyond calcification detection, what other key features do these AI tools offer?

Bunkerhill MAC integrates with the Carebricks generative AI platform for clinical reasoning and action, and supports automated workflows for follow-up and care coordination. ClearRead CT provides pulmonary nodule detection, characterization, measurement, automated tracking and comparison to prior exams, and patented vessel suppression technology.

What types of CT scans are compatible with each tool?

Bunkerhill MAC analyzes routine, non-gated chest CT scans. ClearRead CT performs Coronary Artery Calcification (CAC) scoring on ungated, non-contrast CTs and enhances pulmonary nodule detection in standard, low-dose, non-contrast, and contrast CT scans.

What are the reported benefits in terms of diagnostic accuracy and workflow efficiency?

Bunkerhill MAC aids in early cardiovascular risk identification and care coordination. ClearRead CT is reported to improve detection accuracy with a 29% reduction in missed actionable nodules and reduce reading time by up to 36%.